Articles tagged with: Pregnancy
Results from a recent small Italian study indicate that exposure to antiretroviral drugs, including Viread, during pregnancy does not affect fetal bone metabolism and bone development.
“Antiretroviral therapy taken during pregnancy is not detrimental to bone development and bone health of the fetus/infant. Due to the awareness about the numerous side effects of antiretrovirals, we wanted to verify the safety for the fetus of the therapy,” said Dr. Stefano Mora from the Laboratory of Pediatric Endocrinology at the San Raffaele Scientific Institute of Milan, Italy, and lead author of the …
Short-Course Incivek-Containing Therapy Is Effective For Most People With Untreated Hepatitis C – Results of a Phase 3 clinical trial show that for people with previously untreated hepatitis C who respond well to treatment with Incivek (telaprevir), Pegasys (peginterferon alfa-2a), and ribavirin (Copegus, Rebetol), a 24-week course of treatment is as effective as a 48-week course. Among the study participants who had undetectable hepatitis C virus levels after 4 and 12 weeks of treatment, 92 percent who received 20 weeks of treatment with the three-drug combination followed by 4 more weeks of Pegasys and ribavirin treatment (24 weeks total) were cured of hepatitis C, compared to 88 percent of participants who received 20 weeks of the three-drug combination followed by 28 weeks of the two-drug combination (48 weeks total). For more information, please see the article in U.S. News & World Report or the study in the New England Journal of Medicine (abstract).
Office Of National AIDS Policy To Hold Discussions On National HIV/AIDS Strategy – The Office of National AIDS Policy is planning to hold several discussions with members of the HIV community, including researchers, clinicians, and people with HIV, on implementation of the National HIV/AIDS Strategy. The first talk will be at the University of Alabama in Birmingham on September 27 and is entitled “Incorporation of Prevention and Care Research Into HIV Programs.” Additional talks will be held October 4 in Seattle; October 20 in Philadelphia; late October in Baton Rouge, LA (date to be decided); and early November in Des Moines, IA (date to be decided). Additional dates and locations will be announced later. For more information, please see the AIDS.gov website.
Atlanta Police Department Sued For Discriminating Against HIV-Positive Man – An HIV-positive man who was denied a job as a police officer in Atlanta after a pre-employment medical exam revealed his HIV status has sued the city of Atlanta for discrimination. The man claims that the city violated the Americans with Disabilities Act (ADA) and other federal and state laws; HIV is considered a protected illness under the ADA. Atlanta claims that the man was rejected for reasons other than his HIV status, but that they were also justified in not hiring him because his status represents a “direct threat” to the health and safety of others. For more information, please see the article in The GA Voice.
AIDS Institute Releases New Guidelines On HIV Testing And Treatment During Pregnancy – New York’s AIDS Institute has released two new guides, “HIV Testing During Pregnancy and at Delivery” and “Acute HIV Infection in Pregnancy.” The guides are the first two sections of a new set of guidelines on managing HIV infection in pregnant women. The remaining sections will be posted as they are completed. The guidelines are being formulated in cooperation with the Johns Hopkins University Division of Infectious Diseases. For more information, please see the HIV Testing During Pregnancy and at Delivery and Acute HIV Infection in Pregnancy guidelines.
Results of a recent review indicate that people with HIV may be at an increased risk for infertility, due to both the virus itself and the use of antiretrovirals.
The authors of the review also found that assisted reproduction options can help people with fertility problems and can be a safe choice for HIV serodiscordant couples (a couple in which one partner is HIV positive and the other is HIV negative), although the risk of HIV transmission cannot be eliminated completely.
Based on their results, the authors suggested more research …
Results from a study published this week indicate that many women with HIV never discuss issues specific to HIV-positive women during visits with their clinicians, particularly issues relating to HIV management prior to or during pregnancy.
The researchers speculated that gender-based issues were not discussed during visits with the women’s health care providers because clinicians had a lack of experience, comfort, or knowledge of these issues or expected that patients’ concerns would be attended to by other physicians.
“Clinicians caring for HIV-infected women need to incorporate regular discussions about the …
Results from a recent review show that assisted reproduction techniques are safe and effective for HIV serodiscordant couples where the man is HIV positive and the woman is HIV negative. In all studies reviewed, no HIV infection was detected in the women or their newborns.
The authors of the review suggested that couples in which only the man is HIV positive can safely use assisted reproduction technology to avoid HIV transmission to their uninfected partners and newborns.
However, they also noted that the men in the studies were often required …